… extent of prescriptiondrug mediated phenoconversion remains … Austrian population by
screening claims data from four federal provinces for concomitant use of PGx drugs (ie drugs …

… (avoidable) drug interactions. However, DDIs are difficult to identify in claims data unless an
… Claims data must be merged with patient outcome data to validate whether our definition of …

… Austrian Social Security Organizations, which includes anonymized prescription claims data
from all Austrian … 7.9 million Austrians, 1.7 million of whom are in our study cohort. Besides …

… medication overview of the prescriptions of different health care providers. We use health
claims data of more than 1 million Austrians … EHR systems on drug-drug interaction (DDI) and …

… the codes to the Austrian coding conditions. The Austria Codex [11], a register containing
all drugs which are authorised in Austria, was used to identify potential drug-drug interactions …

… We analysed pseudonymised claims data of all 19 Austrian Statutory health insurances
including all prescriptions of beneficiaries aged ≥ 70 years which were reimbursed by the …

… ), but also an effect of different methods to estimate drug exposure. Many studies used
prescription and claims data to calculate exposure and to detect adverse outcomes. The present …

… drugs on the basis of claims data of Austrian … The Austria Codex [10], a register containing
all drugs which are authorised in Austria, was used to identify potential drug-drug interactions …

… Nirmatrelvir/ritonavir is authorized for the treatment of COVID-19 but has several
contraindications and potential drug–drug interactions (pDDIs) due to ritonavir-induced irreversible …

… prescriptions of lipid-lowering drugs using administrative claims data from diverse regions in
… grant from AstraZeneca, Austria. The funder had no role in study design, data collection and …